Loading the map…
Research and experimental development on biotechnology · Llanelli
Lazarus Transformation
Lazarus Transformation Ltd
Private limited company registered in Llanelli, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to May 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
History
| £ | 2024* | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Fixed assets | ||
| Current assets | ||
| Creditors due within a year | ||
| Net current assets | ||
| Creditors due after a year | ||
| Net assets |
6 balance-sheet lines, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Lazarus Transformation do?
Private limited company registered in Llanelli, classed under “Research and experimental development on biotechnology”.
›How much turnover does Lazarus Transformation make?
Answered in the full report
›Is Lazarus Transformation profitable?
Lazarus Transformation's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Lazarus Transformation?
Answered in the full report
›Where is Lazarus Transformation based?
Its registered office is 7 Cowell Street, First Floor, Llanelli, SA15 1UU, in Llanelli.
›When was Lazarus Transformation founded?
Lazarus Transformation Ltd was incorporated on 10 May 2023.
›Is Lazarus Transformation still trading?
The register lists Lazarus Transformation Ltd as active.